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Echocardiographic Assessment of Left Ventricular Function in
Healthy Horses and in Horses with Heart Disease Using
Pulsed-Wave Tissue Doppler Imaging
T.R. Koenig, K.J. Mitchell, and C.C. Schwarzwald
Background: Assessment of left ventricular (LV) function by tissue Doppler imaging (TDI) is not well established in
horses with heart disease.
Objectives: To describe the use of pulsed-wave (PW) TDI for the assessment of LV function, establish reference intervals,
investigate eﬀects of mitral regurgitation (MR), aortic regurgitation (AR), and primary myocardial disease (MD), and pro-
vide proof of concept for the use of PW TDI in Warmblood horses with heart disease.
Animals: Thirty healthy horses, 38 horses with MR, 25 with AR, 8 with MD.
Methods: Echocardiograms were retrospectively analyzed. Reference intervals were calculated. PW TDI indices of healthy
horses and horses with MR, AR, and MD were compared by one-way ANOVA and Dunnett’s test.
Results: A complete set of PW TDI variables could be obtained in 94 of 101 horses. Variables corresponding to isovolumic
intervals were most diﬃcult to measure. Valvular regurgitation inﬂuenced variables describing isovolumic contraction and ejec-
tion. Horses with MD had signiﬁcantly shortened ETm (118.5 [154.1 to 82.9] ms; mean diﬀerence [95% CI of diﬀerence of
means]), increased PEPm/ETm (0.11 [0.05 to 0.17]), prolonged IMPm (0.28 [0.18 to 0.37]), increased S1 (8.9 [5.2 to 12.6] cm/s), and
decreasedE1 (2.6 [4.7 to0.5] cm/s),Em (14.2 [19.9 to8.5] cm/s), andEm/Am ratio (1.6 [2.6 to0.6]).
Conclusions and Clinical Importance: Pulsed-wave TDI might be useful for detection of LV dysfunction in horses with pri-
mary MD. The clinical value of TDI in horses with MR and AR remains uncertain.
Key words: Aortic regurgitation; Echocardiography; Mitral regurgitation; Myocardial disease; Ventricular function.
Transthoracic echocardiography is considered a stan-dard diagnostic procedure and is well established
for evaluation of cardiac disorders in horses.1,2 The
modalities routinely employed during a comprehensive
echocardiographic workup include two-dimensional
echocardiography (2DE), M-mode echocardiography
(MME), and Doppler echocardiography (DE). These
modalities allow subjective and objective assessment of
cardiac structures and chamber dimensions and serve to
describe and quantify the systolic functional characteris-
tics of the left ventricle (LV). However, diastolic LV
function and regional myocardial function are rarely
Abbreviations:
2DE two-dimensional echocardiography
Am late-diastolic LV wall motion velocity at the time of
atrial contraction
ANOVA analysis of variance
AoDed aortic (sinus) diameter at end diastole
AR aortic regurgitation
BWT body weight
CI conﬁdence interval
DE Doppler echocardiography
E1 LV wall motion velocity during the phase of
isovolumic relaxation
Em early-diastolic LV wall motion velocity during the
phase of rapid ventricular ﬁlling
ETm ejection time
HR heart rate
IMPm index of myocardial performance
IVCTm isovolumic contraction time
IVRTm isovolumic relaxation time
LAAmax maximum left atrial area measured at end systole
LADmax maximum left atrial diameter measured at end systole
LVEF left ventricular ejection fraction
LVFS left ventricular fractional shortening
LVIDd internal diameter of the LV at end diastole
LVIDs internal diameter of the LV at peak systole
LV left ventricle or left ventricular
MD myocardial disease
MME M-mode echocardiography
MMVD myxomatous mitral valve disease
MR mitral regurgitation
MWTd mean wall thickness at end diastole
PADed pulmonary artery (sinus) diameter at end diastole
PEPm pre-ejection period
PW pulsed wave
R2 coeﬃcient of determination
RWTd relative LV wall thickness at end diastole
S1 LV wall motion velocity during the phase of
isovolumic contraction
SD standard deviation
Sm LV wall motion velocity during the ejection phase
TDI tissue Doppler imaging
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considered and cannot be readily evaluated by these
modalities.
Tissue Doppler imaging (TDI) is one of the more
recent technological advances that allows quantitative
characterization of regional wall motion velocities.3,4
Both in people and in small animals, the clinical appli-
cability of TDI has been established and the modality
has been successfully applied for the assessment of sys-
tolic and diastolic LV function and estimation of ven-
tricular ﬁlling pressures.4–7 It might have diagnostic and
prognostic implications in cats and dogs with cardiomy-
opathies8–10 and aid in the diagnosis of subclinical LV
dysfunction in asymptomatic human patients with aor-
tic and mitral regurgitation.11–13
The feasibility, techniques, and reliability of TDI for
characterization of LV radial wall motion in healthy
horses have been investigated.14,15 The potential clinical
use of TDI for the assessment of systolic and diastolic
LV function in horses has been demonstrated in a case
report describing impaired systolic and diastolic LV
function and subsequent recovery in a horse with nutri-
tional myodegeneration16 and in horses exposed to
lasalocid.17 Furthermore, the use of TDI in horses has
also been described for quantitative analysis of stress
echocardiograms,18 for the assessment of left atrial
mechanical function,19–21 for noninvasive measurement
of atrial ﬁbrillation cycle duration,22,23 and to investi-
gate the inﬂuence of atrioventricular interaction on
mitral valve closure and LV isovolumic contraction.24
However, to date, reference intervals for TDI indices
of normal LV systolic and diastolic function have not
been reported in healthy horses. Furthermore, alter-
ations of TDI variables in association with mitral regur-
gitation (MR), aortic regurgitation (AR), and primary
myocardial diseases (MD) have not been described.
The goal of this study was to describe the use of
pulsed-wave (PW) TDI for the assessment of LV func-
tion in a clinical setting, to establish normal reference
intervals for a variety of PW TDI variables in a popula-
tion of clinically healthy Warmblood horses, to investi-
gate the eﬀects of MR, AR, and primary MD on the
respective variables, and to provide proof of concept
for the use of PW TDI variables to assess abnormal
systolic and diastolic LV function in horses with heart
disease.
Materials and Methods
Study Population
The study population was composed of healthy horses and
horses with cardiac disease that had been presented to the Equine
Hospital of the Vetsuisse Faculty, University of Zurich, Switzer-
land, between 2007 and 2012. All horses had been examined by a
single observer (CCS) according to a standard cardiovascular
examination protocol.
Inclusion criteria were Warmblood breed, age >4 years, and the
availability of a complete medical record and of digitally stored
echocardiographic recordings that included pulsed-wave tissue
Doppler tracings of the radial motion of the LV free wall at the
chordal level. Furthermore, horses had to be healthy (based on
medical history, physical examination, and complete routine
echocardiographic examination including two-dimensional, M-
mode, and Doppler echocardiography) or had to be diagnosed
with a primary disorder of MR, AR, or MD. Clinical diagnosis of
MD was based on (i) exclusion of primary valvular, pericardial,
and vascular disease and congenital malformations and (ii) the
presence of two or more of the following ﬁndings: persistent sinus
tachycardia (HR > 50 bpm) at rest that was not related to stress,
excitement, pain, hypovolemia, electrolyte disorders, fever, anemia,
or drug eﬀects; ventricular ectopy; concentric LV hypertrophy (rel-
ative LV wall thickness at end diastole > 0.6) in the absence of
volume depletion; decreased LV systolic function (LV fractional
shortening < 30% based on 2DE and MME); and markedly
increased plasma cardiac troponin I concentrations (cTnI >
0.25 ng/mL). Horses had to have a predominant sinus rhythm
during echocardiographic examination. Horses with atrial ﬁbrilla-
tion or with other cardiac comorbidities were excluded from the
study. The majority of horses were examined without sedation. Of
those that were examined under sedation, only 5 horses with MR
were retained in the study population to assess the inﬂuence of
sedation on TDI variables. In all other groups, the number of
horses examined under sedation was too small for statistical com-
parison; these horses were therefore excluded from the study. The 5
horses included in the analysis had been sedated with detomidinea
only (10–20 mcg/kg IV) or with detomidine (20 mcg/kg IV) and
butorphanolb (10–20 mcg/kg IV) in combination.
Echocardiography
All echocardiographic recordings had been obtained by a single
observer (CCS) according to previously described imaging
standards14,18,19 and had been stored as still images or cine loops
in digital raw data format.c
Routine transthoracic 2DE, MME, and color DE had been per-
formed prospectively by a single observer (CCS) to assess cardiac
structures, valvular competence, chamber dimensions, and LV sys-
tolic function. Basic echocardiographic measurements of left atrial
and left ventricular size and function and dimensions of the great
vessels had been performed as described elsewhere.14,18,19 Grading
of severity of MR and AR, respectively, was achieved by a scoring
system taking into account the duration of the regurgitant signal,
high-velocity jet area and ﬂow disturbance, regurgitant signal
duration, and the number of imaging planes in which the high-
velocity jet could be observed in the receiving chamber.25
The LV had been imaged in tissue velocity imaging moded by
means of a right parasternal short-axis view at the level of the
chordae tendineae.14 For the pulsed-wave TDI (PW TDI) record-
ings, a sample volume 5.9 mm in width at a frequency of 1.7/
3.6 MHz (octave harmonics) had been used. The sample volume
had been placed on the LV free wall so that it covered the suben-
docardial region during diastole and stayed on the myocardium
throughout the cardiac cycle. The velocity scale had been set to a
range of 30 to +20 cm/s. The simultaneous 2D image was frozen
during the PW TDI recordings. Three separate still images and
cine loop recordings, respectively, each containing at least 3 con-
secutive cardiac cycles, had been stored for each echocardiographic
view. A single lead base–apex electrocardiogram had been
recorded simultaneously.
For the purpose of this study, the PW TDI recordings were rean-
alyzed retrospectively by a single observer (TRK) blinded to group
assignment. All measurements were performed on a dedicated com-
puter workstationd as previously described (Supporting Informa-
tion, Figure S1).14 The outer edge of the strongest echo was
measured at standard gain settings, and the sweep speed was set to
66.67 mm/s. Brieﬂy, the following variables were measured: Systolic
wall motion was characterized by the isovolumic contraction veloc-
ity (S1), the ejection velocity (Sm), the pre-ejection period (PEPm),
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the isovolumic contraction time (IVCTm), the ejection time (ETm),
the PEPm/ETm ratio, and the IVCTm/ETm ratio. Diastolic wall
motion was characterized by the isovolumic relaxation velocity (E1),
the early-diastolic velocity during the phase of rapid ventricular ﬁll-
ing (Em), the late-diastolic velocity at the time of atrial contraction
(Am), the isovolumic relaxation time (IVRTm), and the Em/Am ratio.
The index of myocardial performance (IMPm, Tei index) was calcu-
lated as IMPm = (IVCTm + IVRTm)/ETm.
Three representative, nonconsecutive cardiac cycles (i.e, one
cycle in each of the three separately stored images) were measured,
and individual measurements were subsequently averaged for fur-
ther analyses. Cycles during marked transient tachycardia or
immediately following a sinus pause, a 2nd-degree atrioventricular
block or a cycle containing an ectopic beat, were excluded from
analysis. In a subset of horses, cardiac cycles, or both, some com-
ponents (i.e, velocity waves) of the PW TDI recordings were not
clearly discernible. If this was the case, the respective components
were not measured and measurements were termed missing.
Data Analyses and Statistics
Data analyses and statistics were performed by commercially
available computer software.e,f,g
Age, body weight, heart rate, and basic echocardiographic vari-
ables were summarized groupwise by mean and standard deviation
(SD). Summary statistics for PW TDI indices in healthy Warm-
blood horses were calculated by mean, SD, and median, and the
reference intervals were constructed as the interval between the 5th
and the 95th percentile. The relationship of PW TDI indices to
age and body weight, respectively, was assessed by linear regres-
sion analyses.
The basic echocardiographic variables and the PW TDI indices
of healthy horses and horses with MR, AR, and MD, respectively,
were compared by a one-way analysis of variance (ANOVA).
When the F-test revealed signiﬁcant diﬀerences between groups,
Dunnett’s posthoc test was used for pairwise comparison of the
MR, AR, and MD group, respectively, with the group of healthy
horses. The corresponding mean diﬀerences and 95% conﬁdence
intervals (CI) of the diﬀerences of means between groups were also
calculated and reported.
For the assessment of the inﬂuence of sedation on PW TDI
variables in horses with MR, sedated horses were compared to a
subpopulation of 10 unsedated horses that were selected to match
severity of MR, age, and BWT. Diﬀerences in PW TDI variables
were assessed by an unpaired t-test, and the diﬀerence between
means and the 95% CI of the diﬀerence of means between groups
were reported.
Horses with MR and AR, respectively, were grouped according
to regurgitation severity. Horses with trivial and mild regurgitation
and horses with moderate and severe regurgitation, respectively,
were pooled, and the groups were then compared to the group of
healthy horses by a one-way ANOVA followed by Dunnett’s post-
hoc test and corresponding mean diﬀerences and 95% CI of the
diﬀerences of means between groups were calculated.
The level of signiﬁcance was P = .05 for all statistical analyses.
Results
Demographics of the study population, resting heart
rate, and basic echocardiographic measurements are
summarized in Table 1.
The quality of the PW TDI recordings allowed oﬄine
analyses in the majority of horses and cardiac cycles. A
complete set of PW TDI variables could be obtained in
94 of 101 horses. However, some components of the
PW TDI tracings, including IVCTm, S1, IVRTm, and
E1, could not be consistently measured in all horses
(Table 2).
The summary statistics and reference intervals of PW
TDI variables obtained in clinically healthy Warmblood
horses are shown in Table 3. Regression analyses indi-
cated that none of the PW TDI variables was signiﬁ-
cantly related to age or body weight.
Table 4 provides an overview on PW TDI variables
in healthy horses and in horses with MR, AR, and
MD. The results show that PEPm, PEPm/ETm, and S1
were signiﬁcantly increased in horses with MR com-
pared to healthy horses, whereas only Em was signiﬁ-
cantly decreased in horses with AR. Horses with
myocardial disease had signiﬁcantly shortened ETm,
increased PEPm/ETm, prolonged IMPm, increased S1,
decreased E1 and Em, and decreased Em/Am ratio.
The inﬂuence of sedation on PW TDI variables in
horses with MR is shown in Table 5. The results show
that PEPm, PEPm/ETm, and IVCTm/ETm were signiﬁ-
cantly prolonged in the group of sedated horses com-
pared to the unsedated horses matched for MR
severity, breed, age, and BWT.
Tables 6 and 7 summarize the ﬁndings in horses with
MR and AR, respectively, grouped according to sever-
ity of regurgitation. With the exception of S1, none of
the PW TDI variables was signiﬁcantly altered in horses
with trivial and mild MR when compared to healthy
horses. On the other hand, horses with moderate or sev-
ere MR had signiﬁcantly prolonged PEPm and IVCTm,
increased PEPm/ETm, IVCTm/ETm, and IMPm, and
increased S1. Horses with trivial or mild AR had signiﬁ-
cantly prolonged PEPm, shortened ETm, increased
PEPm/ETm, IVCTm/ETm, and IMPm, and decreased
Em. Horses with moderate or severe AR showed no sig-
niﬁcant alterations compared to healthy horses.
Discussion
This study provides reference intervals for PW TDI
variables of LV radial wall motion in a population of
clinically healthy horses and provides proof of concept
for the use of PW TDI for clinical assessment of LV
systolic and diastolic function, with particular value in
horses with myocardial disease.
The population included in this study was limited to
Warmblood horses, because this breed predominates
the caseload of the University of Zurich’s Equine
Hospital. In most horses, adequate quality PW TDI
data were obtained. However, there was a small number
of horses in which measurements were not possible
despite the evaluation of several still images with multi-
ple cardiac cycles captured (Table 2). The most diﬃcult
measurements to obtain were those of the isovolumic
time intervals (IVCTm, IVRTm) and the corresponding
myocardial velocities (S1, E1). The missing data are
related to the short timing and relatively low velocity of
isovolumic events and the inﬂuence of image quality,
motion artifacts, and other individual patient factors,
leading to a low signal-to-noise ratio. In previous stud-
ies evaluating the use of PW TDI and color-coded TDI
measurements in horses, variables characterizing the
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isovolumic periods showed low-to-moderate variability
and, in agreement with this study, they could not be
measured in all horses and in all recorded cycles.14,18
These ﬁndings highlight the importance of optimizing
image quality and of capturing multiple sequential
recordings containing several cardiac cycles to maximize
the chances of obtaining diagnostic information. Fur-
thermore, they emphasize the fact that isovolumic PW
TDI variables should only be measured and interpreted
if the corresponding velocity waves are clearly
identiﬁed.
The reference intervals for PW TDI variables of LV
radial wall motion (Table 3) provided in this study can
serve as a basis for the assessment of PW TDI variables
in Warmblood horses with heart disease. Previously
reported measurement and recording variability and the
inherent biologic variability of PW TDI variables14
should be taken into consideration when interpreting
PW TDI measurements and drawing conclusions about
altered LV systolic function, diastolic function, or both
in individual cases.
In people, dogs, and cats, it is well documented that
myocardial systolic function and diastolic function
decrease with age, leading to a decreased Sm and Em
and increased Am velocities.
2,5,26–30 However, the pre-
sent data did not reveal a signiﬁcant inﬂuence of age on
PW TDI variables in horses. While these ﬁndings might
indicate species-related diﬀerences in regard to the aging
process of myocardial function, it may simply be related
to fact that 23 of the healthy horses included in the
study population were aged ≤15 years and only one
horse was older than 20 years (i.e, 23 years). Therefore,
studies including a population of horses with a wider
age range will be required to deﬁnitively characterize
age-related changes of myocardial function in this
species.
The clinical use of PW TDI for the assessment of LV
mechanical function in horses with valvular regurgita-
tion has not been previously described. In humans and
Table 2. Summary of missing measurements. The
numerator depicts the number of horses and cycles,
respectively, in which the respective variable could not
be measured because the respective peak velocity, time
interval, or both were not clearly discernible. The
denominator depicts the total number of horses
included in the study and the total number of analyzed
cycles, respectively.
Variable
Horses Cycles
Number of horses
in which variable
could not be
measured/total
number of horses
Number of cycles
in which variable
could not be measured/
total number of
analyzed cycles
PEPm 0/101 (0.0%) 7/303 (2.3%)
ETm 0/101 (0.0%) 7/303 (2.3%)
IVCTm 1/101 (1%) 28/303 (9.2%)
IVRTm 5/101 (5%) 58/303 (19.1%)
S1 1/101 (1%) 34/303 (11.2%)
Sm 0/101 (0.0%) 8/303 (2.6%)
E1 6/101 (6%) 61/303 (20.1%)
Em 0/101 (0.0%) 8/303 (2.6%)
Am 0/101 (0.0%) 10/303 (3.3%)
PEPm, pre-ejection period; ETm, ejection time; IVCTm, isovolu-
mic contraction time; S1, isovolumic contraction velocity; Sm, ejec-
tion velocity; IVRTm, isovolumic relaxation time; E1, isovolumic
relaxation velocity; Em, early-diastolic velocity during the phase of
rapid ventricular ﬁlling; Am, late-diastolic velocity at the time of
atrial contraction.
Table 3. Summary statistics and reference intervals of PW TDI variables obtained in clinically healthy, unsedated
Warmblood horses (n=30).
Summary statistics Linear regression
Variable Unit Mean SD Median 5th–95th Percentile
Age Body weight
R2 P value R2 P value
PEPm ms 121 14.1 119 96–149 0.005 .70 <0.001 .88
ETm ms 421 24.7 422 374–475 0.06 .18 0.06 .18
PEPm/ETm 0.29 0.033 0.28 0.24–0.36 0.004 .73 0.01 .56
IVCTm ms 87 12.3 88 65–107 0.01 .57 0.02 .45
IVRTm ms 52 14.5 49 36–90 0.09 .12 0.01 .55
IVCTm/ETm 0.21 0.031 0.21 0.15–0.26 <0.001 1.0 0.06 .21
IMPm 0.33 0.050 0.32 0.25–0.42 0.03 .41 0.08 .16
S1 cm/s 9 2.7 9 6–18 0.06 .20 0.12 .071
Sm cm/s 12 1.4 11 10–15 0.1 .077 <0.001 .87
E1 cm/s 8 2.4 7 4–13 0.06 .22 0.003 .80
Em cm/s 35 5.6 34 27–45 0.09 .11 0.003 .76
Am cm/s 12 3.1 11 8–20 0.05 .25 0.06 .19
Em/Am 3.1 0.77 3.0 2.0–4.6 <0.001 .90 0.05 .26
PEPm, pre-ejection period; ETm, ejection time; PEPm/ETm, PEPm-to-ETm ratio; IVCTm, isovolumic contraction time; IVCTm/ETm,
IVCTm-to-ETm ratio; S1, isovolumic contraction velocity; Sm, ejection velocity; IVRTm, isovolumic relaxation time; IMPm (Tei index),
index of myocardial performance, calculated as IMPm = (IVCTm + IVRTm)/ETm; E1, isovolumic relaxation velocity; Em, early-diastolic
velocity during the phase of rapid ventricular ﬁlling; Am, late-diastolic velocity at the time of atrial contraction; Em/Am, Em-to-Am ratio.
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Table 5. Inﬂuence of sedation on PW TDI variables in Warmblood horses with MR. Continuous data are summa-
rized as mean  SD. Indices that show signiﬁcant diﬀerences are marked by an asterisk.
Variable Unit MR unsedated MR sedated P value
Diﬀerence
between
means
95% CI of
diﬀerence
between means
n 10 5
Severity of MR 5 mild, 5 moderate 4 mild, 1 moderate
Breed WB WB
Age y 6.9  4.1 7.4  5.9 .85 0.5 5.1 to 6.1
BWT kg 556  47 538  66 .55 18 82 to 46
HR bpm 37  6 33  4 .21 4 10 to 2
PEPm ms 125.7  20.9 156.4  29.2 .034* 30.7 2.6 to 58.8
ETm ms 445.5  29.3 419.8  38.4 .17 25.7 64.0 to 12.6
PEPm/ETm 0.28  0.045 0.38  0.089 .016* 0.09 0.02 to 0.17
IVCTm ms 89.3  23.4 118.6  31.9 .063 29.3 1.8 to 60.4
IVRTm ms 58.4  17.7 53.2  11.0 .56 5.2 24.0 to 13.6
IVCTm/ETm 0.20  0.052 0.29  0.091 .035* 0.09 0.007 to 0.16
IMPm 0.33  0.079 0.42  0.111 .11 0.09 0.02 to 0.19
S1 cm/s 10.1  2.2 10.2  2.8 .94 0.1 2.7 to 2.9
Sm cm/s 11.7  1.4 10.4  1.1 .099 1.3 2.9 to 0.3
E1 cm/s 8.7  1.8 7.8  2.0 .39 0.9 3.1 to 1.3
Em cm/s 33.9  4.3 32.0  6.5 .51 1.9 7.9 to 4.1
Am cm/s 13.0  4.6 8.6  1.8 .063 4.4 9.1 to 0.3
Em/Am 3.0  1.2 3.8  1.3 .25 0.8 0.6 to 2.2
For legend, see Table 3.
Table 4. PW TDI indices in healthy horses and horses with cardiac disease. All recordings had been obtained in
unsedated horses. Values marked by an asterisk are signiﬁcantly diﬀerent to values measured in healthy horses.
Variable Unit
Healthy Mitral regurgitation Aortic regurgitation Myocardial disease
ANOVA
P value
n = 30 n = 33 n = 25 n = 8
Mean  SD
Mean  SD
Mean diﬀerence (95% CI of diﬀerence of means)
PEPm ms 120.5  14.1 134.5  20.8* 129.4  22.0 116.4  30.6 .022
14.0 (1.8 to 26.2) 8.9 (4.2 to 22.0) 4.1 (23.3 to 15.1)
ETm ms 420.5  24.7 416.2  42.2 417.1  29.9 302.0  68.6* <.0001
4.3 (26.9 to 18.3) 3.4 (27.6 to 20.8) 118.5 (154.1 to 82.9)
PEPm/ETm 0.29  0.033 0.33  0.067* 0.31  0.063 0.40  0.132* .0004
0.04 (0.002 to 0.08) 0.03 (0.02 to 0.07) 0.11 (0.05 to 0.17)
IVCTm ms 86.6  12.3 99.4  22.7 93.2  24.6 95.8  20.9 .11
12.8 (0.3 to 25.3) 6.6 (6.7 to 20.0) 9.2 (10.4 to 28.8)
IVRTm ms 52.4  14.5 51.0  15.4 48.8  11.6 59.3  31.1 .47
1.4 (11.4 to 8.6) 3.6 (14.6 to 7.5) 6.9 (8.7 to 22.5)
IVCTm/ETm 0.21  0.031 0.24  0.069 0.27  0.22 0.33  0.11 .068
0.04 (0.04 to 0.11) 0.06 (0.02 to 0.14) 0.13 (0.01 to 0.25)
IMPm 0.33  0.050 0.36  0.086 0.34  0.078 0.61  0.21* <.0001
0.03 (0.02 to 0.09) 0.009 (0.05 to 0.07) 0.28 (0.18 to 0.37)
S1 cm/s 9.1  2.7 11.6  2.7* 8.5  2.3 18.0  10.7* <.0001
2.5 (0.1 to 4.8) 0.6 (3.1 to 1.9) 8.9 (5.2 to 12.6)
Sm cm/s 11.6  1.4 12.5  1.9 12.4  1.7 11.5  2.8 .18
0.9 (0.2 to 1.9) 0.7 (0.4 to 1.9) 0.1 (1.8 to 1.6)
E1 cm/s 7.6  2.4 7.8  1.7 6.9  2.3 5.0  1.2* .011
0.15 (1.1 to 1.4) 0.7 (2.2 to 0.7) 2.6 (4.7 to 0.5)
Em cm/s 34.6  5.6 34.2  5.2 30.3  6.2* 20.4  9.6* <.0001
0.4 (4.0 to 3.2) 4.2 (8.1 to 0.4) 14.2 (19.9 to 8.5)
Am cm/s 11.9  3.1 12.6  4.3 12.8  4.6 16.4  8.3 .11
0.7 (2.0 to 3.4) 0.9 (2.0 to 3.8) 4.4 (0.2 to 8.7)
Em/Am 3.1  0.77 3.0  1.24 2.7  1.13 1.5  0.86* .002
0.04 (0.7 to 0.6) 0.4 (1.1 to 0.3) 1.6 (2.6 to 0.6)
For legend, see Table 3.
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dogs with valvular regurgitation, it has been suggested
that TDI might aid in the detection of subclinical LV
dysfunction31–33 and the prediction of increased pul-
monary capillary wedge pressure34 and congestive heart
failure.35–38 Detection of early subclinical LV dysfunc-
tion in horses may provide useful additional informa-
tion, for example, when investigating horses with
murmurs detected on prepurchase examinations or dur-
ing the evaluation of horses with poor performance.
Additionally, further stratiﬁcation of myocardial func-
tion would be useful in clinical trials looking at treat-
ments reducing or slowing the progression of valvular
heart disease in horses.
It needs to be noted that TDI recordings for the
assessment of LV function in humans and small animals
are most commonly obtained from apical views, with
the cursor placed at the mitral valve annulus, and there-
fore describe LV long-axis motion. In adult horses, true
apical views cannot be obtained and adequate align-
ment of the Doppler beam with longitudinal mitral
annular motion cannot be achieved. Therefore, TDI
recordings for the assessment of LV function are usu-
ally limited to radial wall motion of the LV free wall at
the chordal level that can be reliably assessed by stan-
dard short-axis views, allowing optimal alignment with
wall motion.14–16,18 In dogs and cats, both longitudinal
motion and radial motion have been studied and both
were considered diagnostically valuable.9,39 It is possible
however, that long-axis and short-axis motion of the
LV wall might be altered diﬀerently with various dis-
eases such as AR and MR,40 explaining some of the
discrepancies found between this study and previous
studies in humans and small animals. Importantly,
loading conditions, heart rate, and sympathetic tone
aﬀect TDI variables, suggesting that TDI is associated
with the same limitations as conventional echocardiog-
raphy in evaluation of LV systolic and diastolic dys-
function.35
In this study, only TDI variables characterizing the
isovolumic contraction period (i.e, PEPm, PEPm/ETm,
IVCTm, IVCTm/ETm, S1, and IMPm) were signiﬁcantly
altered in horses with MR compared to healthy horses.
Changes in systolic time intervals were in agreement
with those observed in people and small animals.2,41 In
this respect, it is important to understand how isovolu-
mic periods can be aﬀected by valvular insuﬃciencies.
Horses with early-systolic MR, starting before aortic
valve opening, will not have a true isovolumetric period
because of regurgitant ﬂow into the low-pressure left
atrium. Hence, if the regurgitant volume is suﬃciently
large, this will—in addition to potentially altered
myocardial contractility—inﬂuence both the systolic
time intervals and the myocardial velocities during this
period. The time that is required to reach ejection
Table 6. PW TDI measurements in Warmblood horses with mitral regurgitation of diﬀerent severity. All horses
were unsedated. The values marked by an asterisk are signiﬁcantly diﬀerent to the values in healthy horses.
Variable Unit
Healthy Trivial + mild MR Moderate + severe MR
ANOVA
P value
n = 30 n = 16 n = 17
Mean  SD
Mean  SD
Mean diﬀerence (95% CI of diﬀerence of means)
PEPm ms 120.5  14.1 128.6  18.4 140.0  21.8* .0023
8.1 (4.2 to 20.4) 19.5 (7.5 to 31.6)
ETm ms 420.5  24.7 416.8  46.4 415.6  39.2 .88
3.7 (28.4 to 21.0) 4.9 (29.2 to 19.3)
PEPm/ETm 0.29  0.033 0.31  0.060 0.34  0.073* .0043
0.03 (0.01 to 0.06) 0.06 (0.02 to 0.09)
IVCTm ms 86.6  12.3 91.4  24.0 106.8  19.2* .0018
4.9 (7.7 to 17.5) 20.3 (7.9 to 32.6)
IVRTm ms 52.4  14.5 52.3  14.5 49.8  16.7 .84
0.1 (10.9 to 10.6) 2.6 (13.1 to 7.9)
IVCTm/ETm 0.21  0.031 0.22  0.063 0.27  0.068* .0018
0.01 (0.02 to 0.05) 0.06 (0.02 to 0.10)
IMPm 0.33  0.050 0.34  0.082 0.38  0.088* .053
0.01 (0.04 to 0.06) 0.05 (0.004 to 0.10)
S1 cm/s 9.1  2.7 11.3  3.0* 11.8  2.4* .0026
2.2 (0.3 to 4.1) 2.7 (0.8 to 4.6)
Sm cm/s 11.6  1.4 12.4  1.5 12.5  2.2 .14
0.8 (0.4 to 2.0) 0.9 (0.3 to 2.1)
E1 cm/s 7.6  2.4 8.2  1.9 7.4  1.4 .48
0.6 (0.9 to 2.0) 0.3 (1.7 to 1.2)
Em cm/s 34.6  5.6 33.3  6.0 35.1  4.3 .60
1.3 (5.1 to 2.4) 0.5 (3.2 to 4.2)
Am cm/s 11.9  3.1 12.6  4.9 12.7  3.1 .12
0.7 (2.0 to 3.4) 0.7 (1.9 to 3.4)
Em/Am 3.1  0.77 3.1  1.44 3.0  1.05 .96
0 (0.7 to 0.7) 0.1 (0.8 to 0.6)
For legend, see Table 3.
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pressures will increase, and the early-systolic loss in LV
volume will accelerate wall motion kinetics. This, at
least partly, explains the prolonged systolic time inter-
vals (i.e, PEPm, PEPm/ETm, IVCTm, IVCTm/ETm) and
IMPm as well as the faster S1 seen in the horses with
moderate–severe mitral regurgitation when compared
with the healthy horses (Tables 4 and 6).
The ejection phase indices were not signiﬁcantly
altered in horses with MR, although a trend of faster
Sm was observed. This is likely because of a combined
eﬀect of MR-related alterations in myocardial contrac-
tility and loading conditions, which depending on sever-
ity and stage of disease can either facilitate (decreased
afterload and increased contractility related to increased
preload) or impair LV ejection (loss of preload-reserve
and decreased contractility because of myocardial
remodeling and failure). The diastolic PW TDI indices
did not indicate signiﬁcant alterations in LV diastolic
function in horses with MR.
In horses with AR, Em was decreased compared to
healthy horses. The ETm was decreased, whereas PEPm,
PEPm/ETm, IVCTm/ETm, and IMPm were increased in
horses with trivial-to-mild (but not in moderate-to-
severe) AR, indicating mild LV systolic dysfunction
(Tables 4 and 7). The fact that none of the variables
was signiﬁcantly altered in horses with moderate-to-
severe AR suggests that the clinical use of TDI for the
assessment of LV function in horses with AR may be
limited. This seems to be in contrast to ﬁndings in peo-
ple, where reduced Sm, Em, and Am and prolonged
IVCTm, IVRTm, and IMPm provide indices of subclini-
cal LV dysfunction that may serve as prognostic indica-
tors in asymptomatic patients with severe aortic
regurgitation.11–13,42,43 However, it should be noted that
classiﬁcation of valvular regurgitation based on receiv-
ing chamber analysis of the regurgitant jet may not
entirely reﬂect the hemodynamic status in individual
horses. The average degree of LV enlargement reported
in the study population of horses with AR was consid-
ered mild to moderate, and overall LV systolic function
based on LVFS was not impaired (Table 1). Hence, the
data suggest that the horses with moderate-to-severe
AR included in this study still had preserved LV sys-
tolic function. In humans, depending on the chronicity
and severity of disease, the remodeling process is a con-
tinuum, with concentric hypertrophy of the LV seen
with patients that have AR with a preserved LV ejec-
tion fraction (LVEF) whereas eccentric hypertrophy
was found in patients that have reduced LVEF.44 When
classiﬁed on the basis of severity of regurgitation, no
diﬀerence in LV systolic or diastolic TDI variables is
detected between groups of people with moderate or
severe AR, whereas classiﬁcation based on LVEF (pre-
served or reduced) shows marked diﬀerences in TDI
Table 7. PW TDI measurements in Warmblood horses with aortic regurgitation of diﬀerent severity. All horses
were unsedated. The values marked by an asterisk are signiﬁcantly diﬀerent to the values in healthy horses.
Variable Unit
Healthy Trivial + Mild AR Moderate + Severe AR
ANOVA
P value
n = 30 n = 6 n = 19
Mean  SD
Mean  SD
Mean diﬀerence (95% CI of diﬀerence of means)
PEPm ms 120.5  14.1 144.3  20.9* 124.6  20.6 .013
23.9 (6.3 to 41.5) 4.2 (7.4 to 15.7)
ETm ms 420.5  24.7 388.2  22.6* 426.3  26.1 .0073
32.3 (57.7 to 6.9) 5.8 (10.9 to 22.4)
PEPm/ETm 0.29  0.033 0.37  0.054* 0.30  0.055 .0003
0.09 (0.04 to 0.1) 0.01 (0.02 to 0.04)
IVCTm ms 86.6  12.3 106.2  27.9 89.1  22.8 .070
19.6 (0.7 to 38.6) 2.6 (9.9 to 15.0)
IVRTm ms 52.4  14.5 52.8  19.8 47.6  8.5 .48
0.4 (14.4 to 15.2) 4.7 (14.1 to 4.6)
IVCTm/ETm 0.21  0.031 0.27  0.072* 0.21  0.064 .018
0.07 (0.01 to 0.12) 0.01 (0.03 to 0.04)
IMPm 0.33  0.050 0.41  0.124* 0.32  0.047 .018
0.08 (0.01 to 0.14) 0.01 (0.05 to 0.03)
S1 cm/s 9.1  2.7 9.7  1.5 8.1  2.4 .28
0.6 (2.0 to 3.1) 1.0 (2.7 to 0.7)
Sm cm/s 11.6  1.4 12.3  1.4 12.4  1.9 .24
0.7 (0.9 to 2.3) 0.7 (0.3 to 1.8)
E1 cm/s 7.6  2.4 7.6  1.8 6.5  2.5 .27
0.01 (2.6 to 2.6) 1.0 (2.6 to 0.7)
Em cm/s 34.6  5.6 28.2  6.9* 31.0  6.0 .022
6.4 (12.4 to 0.4) 3.6 (7.5 to 0.3)
Am cm/s 11.9  3.1 13.3  4.5 12.7  4.7 .65
1.4 (2.5 to 5.3) 0.8 (1.8 to 3.3)
Em/Am 3.1  0.77 2.3  0.93 2.8  1.18 .19
0.8 (1.7 to 0.2) 0.3 (0.9 to 0.4)
For legend, see Table 3.
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variables between the two groups.44 Throughout the
remodeling process, the degree of LV systolic and dias-
tolic function may change with respect to relaxation,
compliance, and recoil in response to changing wall
thickness, LV volume, ﬁlling pressures, and other fac-
tors. While this is purely hypothetical, it might therefore
be possible that the horses with moderate-to-severe AR
included in this study were at a stage of LV remodeling
that preserved LV function when assessed by TDI
variables.
Overall, based on the current data, the clinical value
of TDI in horses with MR and AR remains uncertain.
It should also be taken into account that none of the
horses included in the study was in congestive heart
failure.
One of the most useful aspects of TDI in human and
small animal echocardiography has been the ability to
detect subtle systolic and diastolic myocardial dysfunc-
tion in patients with a wide variety of diseases including
ischemic heart disease, dilated and hypertrophic car-
diomyopathy, restrictive cardiomyopathy, and constric-
tive pericarditis.5–7,9,45–51 While myocardial diseases are
considered uncommon and are rarely reported in
horses, they might in fact be under-recognized because
of the lack of established diagnostic methods.1 Based
on the current results, there is potential for TDI to
identify LV dysfunction related to myocardial disease in
horses. Previously, data from healthy horses for com-
parison were lacking, but the reference intervals
described in this study can provide a starting point for
recognition of LV diastolic dysfunction caused by these
less commonly identiﬁed diseases. Previous reports indi-
cate that TDI allows detection of systolic and diastolic
LV dysfunction in horses with nutritional and toxic
myocardial damage in horses.16,17 Although there were
only a small number of horses diagnosed with primary
myocardial disease in this study, the results provide fur-
ther proof of concept for the use of PW TDI to detect
LV systolic and diastolic dysfunction in horses with
myocardial disease. Strikingly, the IMPm, a composite
index of systolic and diastolic LV function, was double
that of healthy horses. This was the result of a mark-
edly (and signiﬁcantly) decreased ETm and the slightly
(but not signiﬁcantly) increased IVCTm and IVRTm and
indicated marked LV myocardial dysfunction in aﬀected
horses. Accordingly, PEPm/ETm was signiﬁcantly
increased in horses with myocardial disease compared
to healthy horses, indicating impaired LV systolic func-
tion. It should be noted that a decrease in preload can
also increase pre-ejection period and decrease LV ejec-
tion time,2 causing alterations in systolic time intervals
similar to those seen in this study. Indeed, horses with
MD showed decreased LADmax, LAAmax, and LVIDd
when compared to the healthy horses, indicating a
decrease in preload. Similar ﬁndings, including increases
in RWTd and MWTd that were related to the decrease
in LVIDd, were previously reported in horses with
marked hypohydration.52 However, increases in RWTd
and MWTd were more pronounced in the present study,
and none of the horses with myocardial disease were
clinically volume-depleted at the time of
echocardiography. Therefore, decreased preload and LV
pseudohypertrophy as a result of dehydration is unli-
kely to explain the results of this study. Heart rate must
also be considered a confounding factor when assessing
preload, with higher heart rates resulting in a shorter
ﬁlling time for both the LA and LV. In fact, horses
with myocardial disease had a higher heart rate during
the echocardiography. Increases in IMPm and PEPm/
ETm were previously found in healthy horses with
increased heart rates immediately after exercise,18 but
the increases found in this study were more pronounced
for the respective heart rates. Furthermore, IVCTm and
IVRTm after exercise were not prolonged but showed a
tendency to shorten.18 This suggests that the ﬁndings
obtained in this study, while certainly inﬂuenced by
increased heart rate and sympathetic stimulation, can
largely be attributed to primary myocardial disease.
Doppler-derived transmitral ﬂow velocities (E wave,
A wave, E/A ratio, E-wave deceleration time, and decel-
eration slope) are commonly used in combination with
TDI-derived wall motion velocities (Em, Am, Em/Am
ratio) in humans and small animals for the assessment
of diastolic LV function and ﬁlling pressures.2,5,6 How-
ever, PW Doppler recordings of transmitral ﬂow veloci-
ties are diﬃcult to obtain, are relatively unreliable, and
may not be suitable to detect subtle changes in diastolic
LV function in adult horses.16,19,20,53 Therefore, objec-
tive information about diastolic myocardial function of
horses has historically been unavailable. With the use of
TDI, evaluation of diastolic myocardial function is pos-
sible through measurement of Em and Am velocities and
IVRTm.
14,16 In this study, the horses with myocardial
disease showed a marked decrease in Em with nonsignif-
icant increase in Am velocity and a resulting signiﬁcant
decrease in Em/Am ratio, suggesting impaired ventricular
relaxation with a compensatory increase in left atrial
booster pump function in an attempt to maintain car-
diac output.2,5,6,45 This was not demonstrated in horses
with MR and AR, respectively. The decrease in Em can-
not be explained by higher heart rate, as Em has previ-
ously been shown to increase with tachycardia.18 As
stated above, none of the horses with myocardial dis-
ease were clinically volume-depleted at the time of
echocardiography, suggesting that the results can also
not be explained by a decrease in venous return and
preload. Therefore, the marked decrease in Em and Em/
Am ratio may in fact represent a hallmark of LV dias-
tolic dysfunction in horses with myocardial disease. The
only caveat might be the advanced age of the group of
horses with myocardial disease and the potential inﬂu-
ence of age on Em, Am, and other TDI variables. As
discussed above, the data of this study are inconclusive
concerning the inﬂuence of advanced age (i.e, age >15
year) on myocardial function in horses. But this should
certainly be kept in mind when interpreting TDI record-
ings in older horses with suspected myocardial disease.
Nonetheless, based on the current data, it seems unli-
kely that the alterations in PW TDI variables seen in
horses with myocardial disease were solely age-related.
A few studies have addressed the inﬂuence of seda-
tion on echocardiographic indices of cardiac size and
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function.54–58 Alpha-2 agonists cause a reduction in
heart rate, an increased incidence of 2nd-degree AV
block, and a reduction in LV systolic performance. In
horses with valvular regurgitation, they cause an
increase in valvular regurgitant fraction related to drug-
induced alterations in ventricular ﬁlling (preload) and
systemic arterial pressures (afterload).
Only a small number of sedated horses with MR was
evaluated in this study (Table 5). Unfortunately, a com-
parison of the ﬁndings in the same group of horses
before and after sedation was not possible because of
the retrospective nature of the study. Therefore, the PW
TDI variables of the sedated horses were compared to a
subgroup of normal horses that were selected to match
severity of MR, breed, age, and body weight (Table 5).
Based on the available data, there were signiﬁcant dif-
ferences in PEPm, PEPm/ETm, and IVCTm/ETm in
sedated horses when compared to unsedated horses with
MR. These ﬁndings support the current knowledge that
sedation with detomidine (with or without butorphanol)
suppresses LV systolic function, likely because of a
combined eﬀect on myocardial contractility, loading
conditions, and heart rate.41 Generally, the data suggest
that sedation should be avoided if possible or at least
taken into consideration when PW TDI is used to
assess LV systolic function in horses with MR.
In conclusion, this study documents the clinical use of
PW TDI for assessing LV systolic and diastolic function
in a population of healthy horses and horses with a vari-
ety of cardiac diseases. Variables corresponding to isovo-
lumic intervals (i.e, IVCTm, S1, IVRTm, E1) were most
diﬃcult to measure and could not always be obtained.
Reference intervals for PW TDI variables of radial LV
wall motion were established. Based on this healthy
horse population, there was no evidence of age-related
diastolic myocardial dysfunction as seen in humans and
small animals. However, the age range of the available
population was limited, and the data are therefore incon-
clusive concerning changes in LV function in horses with
advanced age. When assessing LV systolic function in
horses with MR, sedation with detomidine (with or with-
out butorphanol) should be avoided where possible.
Although some variables of LV function were altered in
horses with valvular regurgitation, the clinical value of
PW TDI in horses with MR and AR could not be well
documented and remains uncertain at this time. How-
ever, the available data provide proof of concept for the
use of PW TDI in the assessment of LV function in
horses with primary MD, with particular emphasis on
evaluation of LV diastolic function.
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